Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A caseon-case study in a nationwide pharmacovigilance database.

Guillaume Moulis; Agnès Sommet; Maryse Lapeyre-Mestre; Jean-Louis Montastruc

首页> 外文期刊>Rheumatology >Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A caseon-case study in a nationwide pharmacovigilance database.

【24h】

Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A caseon-case study in a nationwide pharmacovigilance database.

机译：单克隆抗体和可溶性受体对肿瘤坏死因子抑制剂引起的狼疮或类狼疮综合征的风险是否相同？全国性药物警戒数据库中的案例/非案例研究。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Although CIs overlap, there is a clear trend towards a decreased risk with etanercept compared with monoclonal TNFis.

机译：尽管CI重叠，但与单克隆TNFis相比，依那西普有降低风险的明显趋势。

著录项

来源
《Rheumatology》 |2014年第10期|共8页
作者
Guillaume Moulis; Agnès Sommet; Maryse Lapeyre-Mestre; Jean-Louis Montastruc;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
专利

1. Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A caseon-case study in a nationwide pharmacovigilance database. [J] . Guillaume Moulis, Agnès Sommet, Maryse Lapeyre-Mestre, Rheumatology . 2014,第10期

机译：单克隆抗体和可溶性受体对肿瘤坏死因子抑制剂引起的狼疮或类狼疮综合征的风险是否相同？全国性药物警戒数据库中的案例/非案例研究。
2. Tumor necrosis factor-alpha inhibitor-induced lupus-like syndrome presenting as fever of unknown origin in a liver transplant recipient: case report and concise review of the literature. [J] . Page AV, Liles WC Transplantation Proceedings . 2008,第5期

机译：肿瘤坏死因子-α抑制剂诱导的狼疮样综合征表现为肝移植受者的不明原因发热：病例报告和文献综述。
3. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): cl [J] . Drewe E, McDermott EM, Powell PT, Rheumatology . 2003,第2期

机译：抗肿瘤坏死因子受体超家族1B融合蛋白的前瞻性研究，以及抗肿瘤坏死因子受体超家族1A融合蛋白在肿瘤坏死因子受体相关周期性综合征（TRAPS）中的案例研究：
4. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry [O] . Florence Tubach, Dominique Salmon, Philippe Ravaud, -1

机译：抗肿瘤坏死因子单克隆抗体治疗的结核病风险均比可溶性肿瘤坏死因子受体治疗：三年前瞻性法语研究突破了Biotherapies Registry的耐受性
5. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry. [O] . Tubach, Florence, Salmon, Dominique, Ravaud, Philippe, 2009

机译：抗肿瘤坏死因子单克隆抗体治疗的结核病风险高于可溶性肿瘤坏死因子受体治疗的结核病风险：这项为期三年的前瞻性法国研究削减了生物治疗注册的耐受性。

相关主题

Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A caseon-case study in a nationwide pharmacovigilance database.

摘要

著录项

相似文献

相关主题

期刊订阅